Summit Financial Portfolio holdings
Summit Financial supports independent financial advisors, giving them the resources to run their own practices and serve clients. It was set up in 2018 as the successor to Summit Equities, which had provided investment advice and financial planning since 1991. Chief executive Stan Gregor is a co-owner, alongside Merchant Wealth Management Holdings 3, a unit of Merchant Wealth Partners that holds a controlling stake. Its advisors mainly put client money into ETFs and mutual funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$56.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$33.1M |
| 3 |
Ciena
CIEN
|
+$20.4M |
| 4 |
Goldman Sachs Core Bond ETF
GBND
|
+$20M |
| 5 |
NVIDIA
NVDA
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$28M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$26.9M |
| 3 |
Global X Artificial Intelligence & Technology ETF
AIQ
|
+$24.3M |
| 4 |
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
|
+$23.1M |
| 5 |
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
|
+$18.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.88% |
| 2 | Technology | 11.66% |
| 3 | Financials | 5.14% |
| 4 | Industrials | 2.99% |
| 5 | Consumer Discretionary | 2.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1551
DocGo
DCGO
$24.4M
| $139K | ﹤0.01% |
+268,987
| New | +$161K |
2026 Q2
0 quarters
|
|
1552
Cornerstone Strategic Value Fund
CLM
$1.87B
| $134K | ﹤0.01% |
17,754
-877
| -5% | -$6.6K |
2025 Q2
4 quarters
|
|
1553
Brookfield Real Assets Income Fund
RA
$649M
| $131K | ﹤0.01% |
10,198
-100
| -1% | -$1.28K |
2025 Q2
4 quarters
|
|
1554
Redwood Trust
RWT
$393M
| $124K | ﹤0.01% |
+26,259
| New | +$143K |
2026 Q2
0 quarters
|
|
1555
Replimune Group
REPL
$1.67B
| $124K | ﹤0.01% |
11,176
-210
| -2% | -$1.28K |
2025 Q3
3 quarters
|
|
1556
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$530M
| $124K | ﹤0.01% |
14,941
-388
| -3% | -$3.25K |
2025 Q2
4 quarters
|
|
1557
BNY Mellon Strategic Municipals
LEO
$371M
| $118K | ﹤0.01% |
18,332
+493
| +3% | +$3.14K |
2025 Q4
2 quarters
|
|
1558
UiPath
PATH
$7.16B
| $111K | ﹤0.01% |
+10,250
| New | +$109K |
2026 Q2
0 quarters
|
|
1559
Liberty All-Star Equity Fund
USA
$1.83B
| $109K | ﹤0.01% |
+18,739
| New | +$108K |
2026 Q2
0 quarters
|
|
1560
NuScale Power
SMR
$2.31B
| $106K | ﹤0.01% |
+10,520
| New | +$119K |
2026 Q2
0 quarters
|
|
1561
Cardiol Therapeutics
CRDL
$135M
| $105K | ﹤0.01% |
99,109
-4,950
| -5% | -$6.26K |
2025 Q3
3 quarters
|
|
1562
Nuveen Credit Strategies Income Fund
JQC
$681M
| $103K | ﹤0.01% |
21,065
-7,400
| -26% | -$35.7K |
2025 Q2
4 quarters
|
|
1563
C3.ai
AI
$1.91B
| $98.6K | ﹤0.01% |
10,847
-225
| -2% | -$2.14K |
2025 Q4
2 quarters
|
|
1564
Blue Owl Capital
OWL
$7.06B
| $98.4K | ﹤0.01% |
11,251
-2,142
| -16% | -$20.4K |
2026 Q1
1 quarter
|
|
1565
Fermi Inc
FRMI
$1.67B
| $92.9K | ﹤0.01% |
+10,145
| New | +$64.1K |
2026 Q2
0 quarters
|
|
1566
Archer Aviation
ACHR
$3.23B
| $79.4K | ﹤0.01% |
16,789
-6,111
| -27% | -$35.5K |
2025 Q4
2 quarters
|
|
1567
Taysha Gene Therapies
TSHA
$1.35B
| $74.1K | ﹤0.01% |
10,888
-260
| -2% | -$1.54K |
2026 Q1
1 quarter
|
|
1568
SoundHound AI
SOUN
$1.87B
| $67.2K | ﹤0.01% |
10,387
-673
| -6% | -$5.21K |
2025 Q3
3 quarters
|
|
1569
SelectQuote
SLQT
$64M
| $67K | ﹤0.01% |
79,625
| – | – |
2026 Q1
1 quarter
|
|
|
IGR
1570
CBRE Global Real Estate Income Fund
IGR
$556M
| $60.7K | ﹤0.01% |
4,392
+30
| +0.7% | +$418 |
2026 Q1
1 quarter
|
|
1571
Coursera
COUR
$917M
| $57K | ﹤0.01% |
+10,104
| New | +$57.4K |
2026 Q2
0 quarters
|
|
1572
CervoMed
CRVO
$24.2M
| $56.2K | ﹤0.01% |
+18,140
| New | +$63.9K |
2026 Q2
0 quarters
|
|
1573
Medical Properties Trust
MPT
$1.34B
| $52K | ﹤0.01% |
11,028
-908
| -8% | -$4.5K |
2024 Q1
9 quarters
|
|
1574
indie Semiconductor
INDI
$382M
| $51.8K | ﹤0.01% |
+11,527
| New | +$46K |
2026 Q2
0 quarters
|
|
1575
Eledon Pharmaceuticals
ELDN
$225M
| $45.3K | ﹤0.01% |
11,500
| – | – |
2025 Q3
3 quarters
|
|
Similar funds
Summit Financial's Q2 2026 Portfolio in Review
As of Q2 2026, Summit Financial held 1,639 positions worth $9.12B, up 16% from $7.85B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Summit Financial deployed $395M of net new capital in Q2 2026, opening 242 new positions and adding to 773 existing holdings. Its largest new stake was Goldman Sachs Core Bond ETF: 396,755 shares worth $20.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, down from 68% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $28M trimmed.
- Summit Financial's largest Q2 2026 buy was Goldman Sachs Core Bond ETF: 396,755 shares worth $20.1M.
- Summit Financial added most to iShares Ultra Short Duration Bond Active ETF in Q2 2026, an estimated $56.7M increase.
- Summit Financial's biggest Q2 2026 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $28M.
- Summit Financial fully exited VanEck Alternative Asset Manager ETF in Q2 2026, selling an estimated $10.8M.
- Summit Financial's ten largest holdings make up 23% of its $9.12B portfolio in Q2 2026.
- Summit Financial opened 242 new positions and closed 61 in Q2 2026.
- Summit Financial's portfolio value rose 16% quarter-over-quarter to $9.12B.
Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.